114 results
Page 5 of 6
S-4/A
EX-10.14
uj6uxbh70o5
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
8-K
EX-99.1
mnf8hzsh5ae98wxzsy
28 Apr 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
5:13pm
8-K
sytcfsvv0yrku1b
28 Apr 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
5:13pm
425
EX-99.1
6mcbsy 042
28 Apr 21
Business combination disclosure
5:11pm
425
a5ie4a
28 Apr 21
Business combination disclosure
5:11pm
UPLOAD
b6hf20 t1pg
20 Apr 21
Letter from SEC
12:00am
S-4
EX-10.11
osq2mc1tyat5kzt
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.16
el0efs9crqynrszxfz
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.7
9hy x8g3bmmj5ac2
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.10
bdeog44w
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.14
79yjeaa
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
6zjahaw3
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.17
etjpu denm8rz7
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
t5t1zlv
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K/A
EX-10.1
wi5fjtf4eor
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K
EX-99.1
ez6bd7cap1wwm7gxy
15 Mar 21
Public Investor Presentation Transcript
5:20pm
425
EX-99.1
2dgyl vt4jfkk
15 Mar 21
Business combination disclosure
8:20am
8-K
EX-99.1
vbyxyc1rd105w8mj
15 Mar 21
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
8:19am
10-K
z1e0bwik53d dnk
5 Mar 21
Annual report
8:13am
8-K
EX-1.1
z7iyvnn db0af02
10 Jul 20
Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
5:17pm